Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis
- 9 December 2022
- journal article
- review article
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 29 (4) , 441-456
Abstract
No abstract availableKeywords
This publication has 106 references indexed in Scilit:
- Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant RecipientsJAMA, 2021
- Kidney Transplant Recipients Rarely Show an Early Antibody Response Following the First COVID-19 Vaccine AdministrationTransplantation, 2021
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in RussiaThe Lancet, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020
- SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody GenerationImmunity, 2020
- COVID-19 and Solid Organ Transplantation: A Review ArticleTransplantation, 2020
- GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)Journal of Clinical Epidemiology, 2011
- Measuring inconsistency in meta-analysesBMJ, 2003
- Meta-analysis of Observational Studies in EpidemiologyA Proposal for ReportingJAMA, 2000
- Assessing the Quality of Randomized TrialsControlled Clinical Trials, 1999